Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey M. Jonas currently holds 12,500 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey M. Jonas has been a net seller of SAGE stock. They have purchased $600.7K and sold $90.9M worth of shares.
Jeffrey M. Jonas's most recent insider trade was on Jun 10, 2024, when they sold 12,500 shares at $0.00 per share.
Jeffrey M. Jonas serves as Executive at Sage Therapeutics, Inc. (SAGE). They have executed 99 insider transactions totaling $91.5M over their tenure at the company.
Jeffrey M. Jonas holds the position of Executive at Sage Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jeffrey M. Jonas has shown a selling trading pattern, with $600.7K in total purchases and $90.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey M. Jonas was on Mar 18, 2024, when they sold $6.4M worth of KRTX shares. This transaction involved 19,893 shares at $322.73 per share.
Jeffrey M. Jonas currently owns 12,500 shares of Sage Therapeutics, Inc. (SAGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey M. Jonas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey M. Jonas has 99 Form 4 filings on record as an insider at Sage Therapeutics, Inc..
Set alerts for Jeffrey M. Jonas and 40,000+ other insiders.